Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial

Simke W. Waijer, Priya Vart, David Z.I. Cherney, Glenn M. Chertow, Niels Jongs, Anna Maria Langkilde, Johannes F.E. Mann, Ofri Mosenzon, John J.V. McMurray, Peter Rossing, Ricardo Correa-Rotter, Bergur V. Stefansson, Robert D. Toto, David C. Wheeler, Hiddo J.L. Heerspink

Research output: Contribution to journal › Article › peer-review